🇺🇸 FDA
Patent

US 10888617

Cured oil-hydrogel biomaterial compositions for controlled drug delivery

granted A61KA61K47/12A61K47/22

Quick answer

US patent 10888617 (Cured oil-hydrogel biomaterial compositions for controlled drug delivery) held by ATRIUM MEDICAL CORPORATION expires Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ATRIUM MEDICAL CORPORATION
Grant date
Tue Jan 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K47/12, A61K47/22